- Home
- QNCX vs LUCD Comparison
QNCX vs LUCD Comparison
Compare QNCX & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- LUCD
- Stock Information
- Founded
- QNCX 2012
- LUCD 2018
- Country
- QNCX United States
- LUCD United States
- Employees
- QNCX N/A
- LUCD N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- QNCX Health Care
- LUCD Health Care
- Exchange
- QNCX Nasdaq
- LUCD Nasdaq
- Market Cap
- QNCX 34.4M
- LUCD 38.4M
- IPO Year
- QNCX 2019
- LUCD 2021
- Fundamental
- Price
- QNCX $2.08
- LUCD $1.00
- Analyst Decision
- QNCX Strong Buy
- LUCD Strong Buy
- Analyst Count
- QNCX 3
- LUCD 4
- Target Price
- QNCX $9.67
- LUCD $3.69
- AVG Volume (30 Days)
- QNCX 1.1M
- LUCD 530.5K
- Earning Date
- QNCX 11-13-2024
- LUCD 11-13-2024
- Dividend Yield
- QNCX N/A
- LUCD N/A
- EPS Growth
- QNCX N/A
- LUCD N/A
- EPS
- QNCX N/A
- LUCD N/A
- Revenue
- QNCX N/A
- LUCD $4,189,000.00
- Revenue This Year
- QNCX N/A
- LUCD $88.47
- Revenue Next Year
- QNCX N/A
- LUCD $238.94
- P/E Ratio
- QNCX N/A
- LUCD N/A
- Revenue Growth
- QNCX N/A
- LUCD 179.27
- 52 Week Low
- QNCX $0.51
- LUCD $0.63
- 52 Week High
- QNCX $2.14
- LUCD $1.58
- Technical
- Relative Strength Index (RSI)
- QNCX 73.91
- LUCD 57.67
- Support Level
- QNCX $1.56
- LUCD $0.90
- Resistance Level
- QNCX $2.14
- LUCD $1.12
- Average True Range (ATR)
- QNCX 0.21
- LUCD 0.07
- MACD
- QNCX 0.02
- LUCD -0.01
- Stochastic Oscillator
- QNCX 91.89
- LUCD 45.00
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.